Edmund Pezalla, M.D., MPH, is Aetna’s National Medical Director for Pharmaceutical Policy and Strategy. He is responsible for the integration of pharmacy policy and activities into Aetna’s overall strategy and operations. Dr. Pezalla also serves as the lead clinical spokesperson for Aetna in pharmacy related issues and represents Aetna on industry work groups and conferences.
Dr. Pezalla is Aetna’s leading executive on pharmaceutical development, reimbursement strategy and drug evaluation. He is active on projects with the IOM, CDC and FDA as well as MIT’s Center for Biomedical Innovation.
Dr. Pezalla was an invited expert contributing to the President’s Council of Advisors on Science and Technology report: Propelling Innovation in Drug Discovery, Development and Evaluation. In 2014 Dr. Pezalla served as Aetna’s interim Chief Medical Officer for SEHA, the Qatari National Health Insurance Scheme.
Dr. Pezalla is a graduate of Georgetown University College of Arts and Sciences, and Georgetown University School of Medicine. He holds an MPH from the University of California at Berkeley and was a research fellow and doctoral student in Health Management and Policy at the University of Michigan.